Literature DB >> 1516193

Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty.

H C Herrmann1, M Buchbinder, M W Clemen, D Fischman, S Goldberg, M B Leon, R A Schatz, P Tierstein, C M Walker, J W Hirshfeld.   

Abstract

BACKGROUND: The balloon-expandable intracoronary stent developed by Palmaz and Schatz is undergoing clinical evaluation for use in unfavorable anatomic situations and in the prevention of restenosis. Because the stent's mechanism of action would suggest effectiveness in salvaging certain percutaneous transluminal coronary angioplasty (PTCA) failures, we retrospectively examined the results of emergency unplanned coronary artery stenting for failed PTCA procedures, including acute occlusion. METHODS AND
RESULTS: The study population consisted of all US patients receiving emergency unplanned stent implantation in a nonrandomized fashion at seven centers over a 2 1/2-year period (n = 56). All available medical records and angiograms were reviewed to determine retrospectively the reason for stenting: Group 1 consisted of 23 patients with a suboptimal angioplasty result; group 2 included patients with evidence of impending vessel closure after PTCA (n = 15); and group 3 were patients with frank acute occlusion after PTCA (n = 18). The immediate and final (30-day) results of stenting were examined with respect to major complications, which included death, need for coronary artery bypass graft surgery, and occurrence of myocardial infarction. Finally, restenosis rates (greater than or equal to 50% stenosis) based on follow-up angiography were calculated. Baseline characteristics of the study population included a mean +/- SD age of 58 +/- 11 years and a large prevalence of angiographic characteristics generally considered unfavorable for PTCA, which include lesion eccentricity (49%), intimal dissection (9%), or angiographically visible thrombus (6%). After conventional balloon angioplasty, there was an increased incidence of intimal dissection (74%) and thrombus formation (38%), and overall stenosis severity was unchanged (75 +/- 12% versus 70 +/- 27%, p = NS). Successful stent deployment was achieved in 55 (98%) of 56 patients with initial success (freedom from death, surgery, and infarction) in 52 (93%) of 56 patients. The success rate at 1 month fell to 71% primarily because of the occurrence of subacute stent thrombosis (16%) and its associated complications. Overall, major complications occurred in 16 (29%) of 56 patients within 30 days. The only predictor of subacute stent thrombosis in multiple stepwise logistic regression analysis was the presence of angiographically visible thrombus after stenting (p = 0.03). Angiographic restenosis was documented in eight (23%) of 35 eligible patients.
CONCLUSIONS: Emergency stenting may be a useful and effective treatment for failed angioplasty. High initial success rates (greater than 90%) can be achieved, but subsequent complications, often related to subacute thrombosis, occur in a substantial portion of patients. Patients who receive stents on an emergency basis, particularly those with previous acute occlusion, should be considered to be at greater than usual risk for complications and receive more careful anticoagulation and follow-up.

Entities:  

Mesh:

Year:  1992        PMID: 1516193     DOI: 10.1161/01.cir.86.3.812

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

Review 1.  Stent thrombosis: historical perspectives and current trends.

Authors:  D E Cutlip
Journal:  J Thromb Thrombolysis       Date:  2000-08       Impact factor: 2.300

2.  Changes in membrane glycoproteins of circulating platelets after coronary stent implantation.

Authors:  M Gawaz; F J Neumann; I Ott; A May; S Rüdiger; A Schömig
Journal:  Heart       Date:  1996-08       Impact factor: 5.994

Review 3.  Coronary artery stents.

Authors:  A J Stewart; D J Coltart
Journal:  Postgrad Med J       Date:  1996-05       Impact factor: 2.401

4.  The acute effect of stenting with the nitinol self-expanding coil stent: preliminary experience.

Authors:  A Roguin; R Beyar
Journal:  Int J Card Imaging       Date:  1997-12

Review 5.  Endovascular stents: a 'break through technology', future challenges.

Authors:  A G Violaris; Y Ozaki; P W Serruys
Journal:  Int J Card Imaging       Date:  1997-02

6.  Factors affecting the therapeutic choice in patients with multivessel coronary artery disease. The Studio Lombardo Angiografia Multivasali (SLAM) Study Group.

Authors:  S De Servi; S Galli; M Onofri; E Boschetti; R Oberti; L Niccoli; A M De Biase; G Rovelli; M Carini; F Regalia; P Valentini; A Bartorelli
Journal:  Heart       Date:  1997-05       Impact factor: 5.994

7.  Coronary artery stenting in unstable angina pectoris: a comparison with stable angina pectoris.

Authors:  P B Clarkson; M Halim; K K Ray; S Doshi; M Been; H Singh; M F Shiu
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

8.  Coronary Palmaz-Schatz stent implantation in acute myocardial infarction.

Authors:  F J Neumann; H Walter; G Richardt; C Schmitt; A Schömig
Journal:  Heart       Date:  1996-02       Impact factor: 5.994

9.  Early and intermediate term clinical outcome after multiple coronary stenting.

Authors:  A Chauhan; E Vu; D R Ricci; C E Buller; M D Moscovich; S Monkman; I M Penn
Journal:  Heart       Date:  1998-01       Impact factor: 5.994

10.  Effect of the increasing use of coronary angioplasty on outcome at one year in patients with unstable angina.

Authors:  S De Servi; P Valentini; L Angoli; E Bramucci; P Barberis; G Mariani; G Specchia
Journal:  Br Heart J       Date:  1995-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.